Literature DB >> 10488870

Culture-negative septic arthritis in children.

R M Lyon1, J D Evanich.   

Abstract

To compare the incidence, characteristics, treatment course, and clinical outcome of children with culture-negative versus culture-positive septic arthritis, we reviewed all 105 children treated for septic arthritis at our institution from 1990 to 1997. Seventy-six children had a clinical presentation consistent with an isolated joint infection. All underwent a joint aspiration with fluid analysis including culture. All were followed up until resolution of their symptoms. Culture of the synovial aspirates identified an etiologic organism in only 30% of cases. No significant differences existed between the culture-positive and culture-negative groups in most clinical and laboratory criteria. No other diagnoses were demonstrated. All patients underwent joint drainage, received comparable antibiotic therapy, and had complete resolution of their infections. The current literature reports deceptively low rates of 18-48% for culture-negative septic arthritis. Seventy percent of children with clinical findings of septic arthritis had negative synovial fluid cultures. As the two culture groups were comparable and no other diagnoses were demonstrated, the culture-negative cases were likely infections. Thus we recommend the same aggressive treatment in those cases with and without identification of a causative organism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488870

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  15 in total

1.  A case of bilateral suppurative arthritis of hip joint with concomitant pyomyositis.

Authors:  Halil Atmaca; Kaya Memişoğlu; Zeki Yumuk; Adem Aydın
Journal:  Balkan Med J       Date:  2012-09       Impact factor: 2.021

2.  Excessive extremity shortness due to septic arthritis : Case report of treatment with two surgical procedures.

Authors:  Cengiz Isik; Tacettin Ayanoglu; Metin Celik; Emre Arıkan; Mahmut Timur Turhan
Journal:  Orthopade       Date:  2021-03-04       Impact factor: 1.087

3.  Image-guided percutaneous bone biopsy for pediatric osteomyelitis: correlating MRI findings, tissue pathology and culture, and effect on clinical management.

Authors:  Christopher Yen; Shivam Kaushik; Sudhen B Desai
Journal:  Skeletal Radiol       Date:  2022-07-26       Impact factor: 2.128

4.  Effects of immunocompromised status on diagnostic criteria in septic arthritis.

Authors:  Joseph P Costello; Moses I Markowitz; Dylan Luxenburg; Michael G Rizzo; Rami H Mahmoud; Spencer W Barnhill; Fernando E Vilella-Hernandez
Journal:  J Orthop       Date:  2022-08-10

Review 5.  Epidemiology and outcome of septic arthritis in childhood: a 16-year experience and review of literature.

Authors:  Joseph Carolin Jeyanthi; Khin Myo Yi; John Carson Allen; Sumanth Kumar Gera; Arjandas Mahadev
Journal:  Singapore Med J       Date:  2020-09-21       Impact factor: 3.331

6.  Evaluation of the current use of imaging modalities and pathogen detection in children with acute osteomyelitis and septic arthritis.

Authors:  Nora Manz; Andreas H Krieg; Ulrich Heininger; Nicole Ritz
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

7.  A Neonatal Septic Arthritis Case Caused by Klebsiella pneumoniae: A Case Report.

Authors:  Tamer Ozsari; Gülhan Bora; Özmert M A Ozdemir; Ilknur Kiliç
Journal:  J Clin Diagn Res       Date:  2016-02-01

8.  Differences in MRI findings between subgroups of recent-onset childhood arthritis.

Authors:  Eva Kirkhus; Berit Flatø; Oystein Riise; Tor Reiseter; Hans-Jørgen Smith
Journal:  Pediatr Radiol       Date:  2010-12-07

9.  Laboratory predictors for risk of revision surgery in pediatric septic arthritis.

Authors:  Jessica J M Telleria; Rosemary A Cotter; Viviana Bompadre; Suzanne E Steinman
Journal:  J Child Orthop       Date:  2016-05-12       Impact factor: 1.548

10.  Neonatal Candida arthritis.

Authors:  Saurabh Sharma; Kapil Gangwal
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.